Literature DB >> 11421370

Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.

M A Nafeh1, A Medhat, M Shehata, N N Mikhail, Y Swifee, M Abdel-Hamid, S Watts, A D Fix, G T Strickland, W Anwar, I Sallam.   

Abstract

The prevalence of antibody to hepatitis C virus (anti-HCV) was determined in a cross-sectional survey in a village in Upper Egypt. Exposure and demographic characteristics were obtained through a questionnaire. Antibody to hepatitis C virus was assessed using a second generation enzyme immunoassay, and the presence of HCV RNA was tested using a reverse transcriptase-polymerase chain reaction. Collection of blood samples was targeted at those > or = 5 years old, and obtained from 62.8%. This report describes the community, the HCV infection characteristics of the subjects, and evaluates some factors associated with presence of anti-HCV. Of the 6,031 participants, 522 (8.7%) were anti-HCV positive. Prevalence was higher among males than females (11.3% versus 6.5%; P < 0.001). It was greater among those > 30 years of age than among those < or = 30 years of age (20.0% versus 3.6%; P < 0.001). Those who were less educated, farmed, provided health care, and were currently married had a significantly higher anti-HCV prevalence than those who were not; however, these associations were not significant after adjusting for age. Although active infections with Schistosoma haematobium were not associated with anti-HCV, a history of past infection was (age-adjusted risk ratio [RR] = 2.1, 95% confidence interval [CI] = 1.8, 2.4); 134 persons who had a history of receiving parenteral anti-schistosomal therapy had a higher age-adjusted RR (3.0; 95% CI = 2.5, 3.7) for anti-HCV than those who did not. Hepatitis C virus RNA was detected in 62.8% of the anti-HCV positive subjects, without significant variation by age, gender, education, or marital status. The prevalence of anti-HCV in Upper Egypt is high, albeit lower than in Lower Egypt, with continuing but limited transmission indicated by the lower prevalence in residents < or = 30 years old.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11421370

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

2.  Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus.

Authors:  Mohamed Abdel-Hamid; Mai El-Daly; Sherif El-Kafrawy; Nabiel Mikhail; G Thomas Strickland; Alan D Fix
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

5.  Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample.

Authors:  Ibtihal Ibrahim; Hala Salah; Hanan El Sayed; Hader Mansour; Ahmed Eissa; Joel Wood; Warda Fathi; Salwa Tobar; Ruben C Gur; Raquel E Gur; Faith Dickerson; Robert H Yolken; Wafaa El Bahaey; Vishwajit Nimgaonkar
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

6.  Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.

Authors:  Doa'a A Saleh; Fatma Shebl; Mohamed Abdel-Hamid; Shaker Narooz; Nabiel Mikhail; Manal El-Batanony; Sherif El-Kafrawy; Mai El-Daly; Soraya Sharaf; Mohamed Hashem; Samer El-Kamary; Laurence S Magder; Sonia K Stoszek; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-06-02       Impact factor: 2.184

7.  Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy.

Authors:  Ayman El Nakeeb; Ahmad M Sultan; Tarek Salah; Mohamed El Hemaly; Emad Hamdy; Ali Salem; Ahmed Moneer; Rami Said; Ahmed AbuEleneen; Mostafa Abu Zeid; Talaat Abdallah; Mohamed Abdel Wahab
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

8.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

9.  Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan.

Authors:  Mustafa Abdalla Ali Abou; Yassir Mohammed Eltahir; Abdelwahid Saeed Ali
Journal:  Virol J       Date:  2009-09-23       Impact factor: 4.099

10.  Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Authors:  Abdel-Rahman N Zekri; Hanaa M Alam El-Din; Abeer A Bahnassy; Naglaa A Zayed; Waleed S Mohamed; Suzan H El-Masry; Sayed K Gouda; Gamal Esmat
Journal:  Comp Hepatol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.